Life Line Ultra Care Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 03-01-2025
- Paid Up Capital ₹ 1.49 Cr
as on 03-01-2025
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.00 M
as on 03-01-2025
- Revenue 44.25%
(FY 2022)
- Profit 34321.73%
(FY 2022)
- Ebitda 132.52%
(FY 2022)
- Net Worth 8.07%
(FY 2022)
- Total Assets 11.05%
(FY 2022)
About Life Line Ultra Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.49 Cr.
The company has closed loans amounting to ₹7.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manvendra Sharma, Anita Sharma, Niyati Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110UP2003PTC027319
- Company No.
027319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Life Line Ultra Care?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naman Sharma  | Director | 27-Jun-2014 | Current |
| Manvendra Sharma | Director | 11-Mar-2003 | Current |
| Anita Sharma | Director | 11-Mar-2003 | Current |
| Niyati Sharma | Director | 05-Oct-2011 | Current |
Financial Performance of Life Line Ultra Care.
Life Line Ultra Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.25% increase. The company also saw a substantial improvement in profitability, with a 34321.73% increase in profit. The company's net worth moved up by a moderate rise of 8.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Life Line Ultra Care?
In 2022, Life Line Ultra Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jai Hospital And Research Centre Private LimitedActive 31 years 6 monthsManvendra Sharma and Anita Sharma are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Pnb Housing Financing Limited Creation Date: 25 Feb 2006 | ₹7.00 M | Satisfied |
How Many Employees Work at Life Line Ultra Care?
Unlock and access historical data on people associated with Life Line Ultra Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Life Line Ultra Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Life Line Ultra Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
